Bcl-2 family expression in salivary glands from patients with primary Sjogren's syndrome: Involvement of Bax in salivary gland destruction

Clinical Immunology and Immunopathology

Volumn 88, Issue 2, 1998, Pages 133-141

  Kong, Liping ^a   Ogawa, Noriyoshi ^b   McGuff, H Stan ^a   Nakabayashi, Toru ^a   Sakata, Ken Mei ^a   Masago, Reiji ^c   Vela Roch, Norma ^a   Talal, Norman ^a   Dang, Howard ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

Author keywords

Apoptosis; Bcl 2; Salivary glands; Sjogren's syndrome

Indexed keywords

ACINAR CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; DNA NICK TRANSLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; SALIVARY GLAND; SJOEGREN SYNDROME;

EID: 0031658474     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4556     Document Type: Article

References (55)

1. Greenspan, J. S., Daniels, T. E., and Talal, N., The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg. 37, 217-229, 1974.
2. Kong, L., Ogawa, N., Nakabayashi, T., Liu, G. T., D'Souza, E., McGuff, H. S., Guerrero, D., Talal, N., and Dang, H., Fas and Fas ligand expression in salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 39, 87-97, 1997.
3. Alpert, S., Kang, H.-I., Weissman, I., and Fox, R. I., Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum. 37, 1046-1054, 1994.
4. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H. G., and Reed, J. C., Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am. J. Pathol. 145, 1323-1336, 1994.
5. Monaghan, P., Robertson, D., Amos, T. A. S., Dyer, M. J. S., Mason, D. Y., and Greaves, M. F., Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 40, 1818-1825, 1992.
6. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C., Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361, 365-369, 1993.
7. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C., Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374, 733-736, 1995.
8. Lin, J.-K., and Chou, C.-K., In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res. 52, 385-388, 1992.
9. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74, 609-619, 1993.
10. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D., and Barr, P. J., Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736-739, 1995.
11. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H.-G., and Reed, J. C., Interactions among members of the Bcl-2 protein family analysed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91, 9238-9243, 1994.
12. Wrone-Smith, T., Johnson, T., Nelson, B., Boise, L. H., Thompson, C. B., Nunez, G., and Nickoloff, B. J., Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146, 1079-1088, 1995.
13. Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., and Dörken, B., Overexpression of the death-promoting gene bax-a which is down-regulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Invest. 97, 2651-2659, 1996.
14. Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., and Harris, A. W., Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88, 8661-8665, 1991.
15. Vitali, C., Bombardieri, S., Moutsopoulos, H., Balestrieri, G., Bencivelli, W., Bernsten, R., Bjerrum, K., Braga, S., Coll, J., de Vita, S., Drosos, A., Ehrenfeld, M., Hatron, P., Hay, E., Isenberg, D., Janin, A., Kalden, J., Kater, L., Konttinen, Y., Maddison, P., Maini, R., Manthrope, R., Mayer, O., Ostuni, P., Pennec, Y., Prausse, Y., Richards, A., Sauvezie, B., Schiodt, M., Sciunto, M., Scully, C., Shoenfeld, Y., Skopouli, F., Smolen, J., Snaith, M., Tishler, M., Todesco, S., Valesini, G., Venables, P., Wattiaux, M., and Youinou, P., Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective, concerted action supported by the European Community. Arthritis Rheum. 36, 340-347, 1993.
16. Chisholm, D. M., and Mason, D. K., Labial salivary gland biopsy in Sjögren's syndrome. J. Clin. Pathol. 21, 656-660, 1968.
17. Taylor, C. R., Shi, S.-R., Chen, C., Young, L., Yang, C., and Cote, R. J., Comparative study of antigen retrieval heating methods: Microwave, microwave and pressure cooker, autoclave, and steamer. Biotech. Histochem. 71, 263-270, 1996.
18. van den Berg, F. M., Baas, I. O., Polak, M. M., and Offerhaus, G. J. A., Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am. J. Pathol. 142, 381-385, 1993.
19. Laemmli, V. K., Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-685, 1970.
20. Towbin, H., Staehelin, T., and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354, 1979.
21. Alard, P., Lantz, Sebaugh, M., Calvo, C. F., Weill, D., Chavanel, G., and Senik, A., A versatile ELISA-PCR assay for mRNA quantitation from a few cells. BioTechniques 15, 730-737, 1993.
22. Ogawa, N., Dang, H., Kong, L., Anaya, J.-M., D'Souza, E., Liu, G. T., and Talal, N., Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome. Arthritis Rheum. 39, 1875-1885, 1996.
23. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Lieberman, D. A., Hoffman, B., and Reed, J. C., Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805, 1994.
24. Osborne, R. J., Merlo, G. R., Kitsudomi, T., Venesio, T., Liscia, D. S., Cappa, A. P. M., Chiba, I., Takahashi, T., Nau, M. M., Callahan, R., and Minna, J. D., Mutations in p53 gene primary human breast cancers. Cancer Res. 51, 6194-6198, 1991.
25. Chung, R., Whaley, J., Kley, N., Anderson, K., Louis, D., Hettlich, C., Freiman, R., Hedleywhyte, E. T., Martuza, R., Jenkins, R., Yandell, D., and Seizinger, B. R., TP53 gene mutation and 17p deletions in human astrocytomas. Genes Chromosomes Cancer 3, 323-331, 1991.
26. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B., Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355, 846-847, 1992.
27. Iggo, R., Gatter, K., Barek, J., Lane, D., and Harris, A. L., Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335, 675-679, 1990.
28. Ellis, R. E., Yuan, J., and Horvitz, H. R., Mechanism and function of cell death. Annu. Rev. Cell Biol. 7, 663-698, 1991.
29. Carson, D. A., and Ribeiro, J. M., Apoptosis and disease. Lancet 341, 1251-1254, 1993.
30. Thompson, C. B., Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462, 1995.
31. Barr, P. J., and Tomei, D. L., Apoptosis and its role in human disease. Biotechnology 12, 487-493, 1994.
32. Ogawa, N., Dang, H., and Talal, N., Apoptosis and autoimmunity. J. Autoimmun. 8, 1-20, 1995.
33. Mountz, J., Wu, J., Cheng, J., and Zhou, T., Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37, 1415-1420, 1994.
34. White, E., Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15, 1996.
35. Mountz, J., and Talal, N., Retroviruses, apoptosis and autogenes. Immunol. Today 14, 532-536, 1993.
36. Boise, L. H., Gonzalez-Gracia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B., bcl-x, a blc-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608, 1993.
37. Hockenberry, D., Nuñez, G., Milliman, C., Schreiber, R., and Korsmeyer, S. J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336, 1990.
38. Lin, E. Y., Orlofsky, A., Berger, M. S., and Prystowsky, M. B., Characterization of Al, a novel hemopoietic-specific early response gene with sequence similiarity to bcl-2. J. Immunol. 151, 1979-1988, 1993.
39. Oltavi, Z. N., and Korsmeyer, S. J., Checkpoints of dueling dimers foil death wishes. Cell 79, 189-192, 1994.
40. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J., Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92, 7834-7838, 1991.
41. Ohsako, S., Hara, M., Harigai, M., Fukasawa, C., Krajewski, S., Reed, J. C., and Kashiwazaki, S., The bcl-2/bax ratio of lymphocytes from human systemic lupus erythematosus patients. Jpn. J. Rheumatol. 7, 305-313, 1997.
42. Reed, J. C., Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6, 1994.
43. Kitada, S., Krajewski, S., Miyashita, T., Krajewska, M., and Reed, J. C., γ-Radiation induces upregulation of bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12, 187-192, 1996.
44. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V.-M., Niskanen, E., Nordling, S., and Reed, J. C., Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55, 4471-4478, 1995.
45. Kong, L., Robinson, C. P., Yamachika, S., Humphreys-Beher, M. G., Dang, H., and Talal, N., Salivary gland apoptosis in the absence of lymphocytes in NOD mice. Arthritis Rheum. 40, S223, 1997.
46. Sakata, K.-M., Sakata, A., Kong, L., Dang, H., and Talal, N., Role of Fas/FasL interaction in physiology and pathology: The good and the bad. Clin. Immunol. Immunopathol. 87, 1-7, 1998.
47. Miyashita, T., and Reed, J. C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299, 1995.
48. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M., Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352, 345-347, 1991.
49. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J., Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495-4499, 1992.
50. Reich, N. C., and Levine, A. J., Growth regulation of a cellular tumour antigen, p53, in non-transformed cells. Nature 308,199-201, 1984.
51. Rodrigues, N. R., Roman, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P., p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA 87, 7555-7559, 1990.
52. Li, X., Tsuji, T., Wen, S., Sobhan, F., Wang, Z., and Shinozaki, F., Cytoplasmic expression of p53 protein and its morphological features in salivary gland lesions. J. Oral Pathol. Med. 24, 201-205, 1995.
53. Boehme, S. A., and Lenardo, M. J., TCR-mediated death of mature lymphocytes occurs in the absence of p53. J. Immunol. 156, 4075-4078, 1996.
54. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dheim, J., Trauth, B. C., Ponsting, H., and Krammer, P. H., Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267, 10709-10715, 1992.
55. Itoh, N., and Nagata, S., A novel protein domain required for apoptosis. J. Biol. Chem. 268, 10932-10937, 1993.